Publications

2010

Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance.

López M, Varela L, Vázquez MJ, Rodríguez-Cuenca S, González CR, Velagapudi VR, Morgan DA, Schoenmakers E, Agassandian K, Lage R, Martínez de Morentin PB, Tovar S, Nogueiras R, Carling D, Lelliott C, Gallego R, Orešič M, Chatterjee K, Saha AK, Rahmouni K, Diéguez C & Vidal-Puig A

Nature Medicine (2010) 16:1001-1008.

Diabesity, Functional Obesomics , Molecular Metabolism, NeurObesity

2009

Evidence for distinct antagonist-revealed functional states of 5-hydroxytryptamine(2A) receptor homodimers.

Brea J, Castro M, Giraldo J, López-Giménez JF, Padín JF, Quintián F, Cadavid MI, Vilaró MT, Mengod G, Berg KA, Clarke WP, Vilardaga JP, Milligan G, Loza MI.

Mol Pharmacol. 2009 Jun;75(6):1380-91.

Pharmacology Applied to Drug Discovery

2008

The AMPK-malonyl-CoA-CPT1 axis in the control of hypothalamic neuronal function.

López M, Saha AK, Diéguez C & Vidal-Puig A

Cell Metabolism 8:176.

NeurObesity

1013

Chronic sympathoexcitation through loss of Vav3, a Rac1 activator, results in divergent effects on metabolic syndrome and obesity depending on diet.

Menacho-Márquez M, Nogueiras R, Fabbiano S, Sauzeau V, Al-Massadi O, Diéguez C, Bustelo XR.

Cell Metab. 2013 Aug 6;18(2):199-211

Functional Obesomics , Molecular Metabolism

208

Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin.

López M, Lage R, Saha AK, Pérez-Tilve D, Vázquez MJ, Varela L, Sangiao-Alvarellos S, Tovar S, Raghay K, Rodríguez-Cuenca S, Deoliveira RM, Castañeda T, Datta R, Dong JZ, Culler M, Sleeman MW, Álvarez C, Gallego R, Lelliott CJ, Carling D, Tschöp MH, Diéguez C & Vidal-Puig A

Cell Metabolism (2008) 7:389-399.

Diabesity, Functional Obesomics , Neoplasia & Endocrine Differentiation , NeurObesity